Metabolic control and prevalent cardiovascular disease in Non-Insulin- Dependent Diabetes Mellitus (NIDDM): The NIDDM patient outcomes research team

American Journal of Medicine

Volumn 102, Issue 1, 1997, Pages 38-47

  Meigs, James B ^a,b   Singer, Daniel E ^a   Sullivan, Lisa M ^b   Dukes, Kimberly A ^b   D'Agostino, Ralph B ^c   Nathan, David M ^a   Wagner, Edward H ^d   Kaplan, Sherrie H ^b   Greenfield, Sheldon ^b  

^a BOSTON UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Grp Hlth Coop of Puget Sound ^*  (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; TIME FACTORS;

EID: 0031046184     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00383-X     Document Type: Article

References (42)

1. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS) VIII. Study design, progress, and performance. Diabetologia. 1991;34:877-890.
2. Hiller R, Sperduto RD, Podgor MJ, et al. Diabetic retinopathy and cardiovascular disease in type II diabetics: the Framingham Heart Study and the Framingham Eye Study. Am J Epidemiol 1988;128:402-409.
3. Moss SE, Klein R, Klein BEK. Cause-specific mortality in a population-based study of diabetes. Am J Public Health. 1991;81:1158-1162.
4. Morrish NJ, Stevens LK, Head J, et al. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: causes and death rates. Diabetologia. 1990;33:538-541.
5. Wingard DL, Barrett-Connor E, Criqui MH, Suarez L. Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. Am J Epidemiol 1983;117:19-26.
6. Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J. 1985;110:1100-1107.
7. Haffner SM, Stern MP, Hazuda HP, et al. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of diabetes? JAMA. 1990;263:2893-2898.
8. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1979;241:2035-2038.
9. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141-1147.
10. Pettitt DJ, Knowler WC, Lisse JR, Bennett PH. Development of retinopathy and proteinuria in relation to plasma glucose concentrations in Pima Indians. Lancet. 1980;2:1050-1052.
11. Nathan DM, Singer DE, Godine JE, et al. Retinopathy in older type II diabetics: association with glucose control. Diabetes. 1986;35:797-801.
12. Klein R, Klein BEK, Moss SE, et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA. 1988;260:2864-2871.
13. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM. 1993;329:977-986.
14. 1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes. 1992;41:202-208.
15. Uusitupa MIJ, Niskanen LK, Siitonen O, et al. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 1993;36:1175-1184.
16. Laakso M, Lehto S, Penttila I, Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation. 1993;88:1421-1430.
17. Fu C-C, Chang C-J, Tseng C-H, et al. Development of macrovascular diseases in NIDDM patients in northern Taiwan. Diabetes Care. 1993;16:137-143.
18. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 1994;43:960-967.
19. Moss SE, Klein R, Klein BEK, Meuer SM. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med. 1994;154:2473-2479.
20. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes. 1970;19(suppl 2):787-830.
21. Abraira C, Johnson N, Colwell J, et al. VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): results of the completed feasability trial. Diabetes. 1994;43(suppl 1):59A.
22. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1994;6:616-623.
23. Greenfield S, Kaplan SH, Silliman RA, et al. The uses of outcomes research for medical effectiveness, quality of care, and reimbursement in type II diabetes. Diabetes Care. 1994;17(suppl 1):32-39.
24. Meigs JB, Singer DE, Nathan DM, et al. Tracking of hemoglobin A1c in the original cohort of the Framingham Heart Study. J Clin Epidemiol. 1995;49:411-417.
25. Criqui MH, Frankville DD, Barrett-Connor E, et al. Change and correlates of change in high and low density lipoprotein cholesterol after six years: a prospective study. Am J Epidemiol. 1983;118:52-59.
26. Izzo C, Grillo F, Murador E. Improved method for determination of high-density lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. Clin Chem. 1981;27:371-374.
27. SAS/STAT User's Guide. Version 6, 4th ed. Cary, NC: SAS Institute, Inc.; 1989.
28. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley-Interscience; 1989.
29. Hiss RG, Anderson RM, Hess GE, et al. Community diabetes care: a 10-year perspective. Diabetes Care. 1994;17:1124-1134.
30. Wilson PWF, Anderson KM, Kannel WB. Epidemiology of diabetes mellitus in the elderly: the Framingham Study. Am J Med. 1986;80(suppl 5A):3-9.
31. Laakso M, Ronnemaa T, Pyorala K, et al. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care. 1988;11:449-463.
32. Scheidt-Nave C, Barrett-Connor E, Wingard DL. Resting electrocardiographic abnormalities suggestive of asymptomatic ischemic heart disease associated with non-insulin dependent diabetes mellitus in a defined population. Circulation. 1990;81:899-906.
33. Rewers M, Shetterly SM, Baxter J, et al. Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin dependent diabetes mellitus in a biethnic Colorado population. Am J Epidemiol. 1992;12:1321-1330.
34. Andersson DKG, Svardsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care. 1995;18:1534-1543.
35. Knuiman MW, Welborn TA, McCann VJ, et al. Prevalence of diabetic complications in relation to risk factors. Diabetes. 1986;35:1332-1339.
36. Nelson RG, Ghodes DM, Everhart JE, et al. Lower-extremity amputations in NIDDM: 12-year follow-up study in Pima Indians. Diabetes Care. 1988;11:8-16.
37. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus: a case-control study. Ann Intern Med. 1992;117:97-105.
38. Lee JS, Lu M, Lee VS, et al. Lower-extremity amputation: incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study. Diabetes. 1993;42:876-882.
39. Lehto S, Ronnemma T, Pyorala K, Laakso M. Risk factors predicting lower extemity amputations in patients with NIDDM. Diabetes Care. 1996;19:607-612.
40. Savage PJ. Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention. Ann Intern Med. 1996;124(1 pt 2):123-126.
41. Harlow SD, Linet MS. Agreement between questionnaire data and medical records. Am J Epidemiol. 1989;129:233-248.
42. Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health. 1989;79:1554-1556.